Erasca, Inc. (ERAS) Market Cap
- 2026-09-03: Market Cap $5.69B.
- 2026-08-04: Market Cap $6.43B.
- 2026-06-30: Market Cap $5.73B.
- 2026-05-05: Market Cap $3.11B.
Historical market capitalization from contemporaneous retained split-adjusted close and filed split-adjusted shares outstanding.
- Available history
- 2021-08-15 to 2026-09-03
- Data captured
Historical Market Cap
| Date | Market Cap |
|---|
| 2026-09-03 | $5.69B |
|---|
| 2026-08-04 | $6.43B |
|---|
| 2026-06-30 | $5.73B |
|---|
| 2026-05-05 | $3.11B |
|---|
| 2026-03-31 | $5.03B |
|---|
| 2026-03-05 | $4.83B |
|---|
| 2025-12-31 | $1.06B |
|---|
| 2025-11-05 | $624.17M |
|---|
| 2025-09-30 | $618.49M |
|---|
| 2025-08-05 | $425.51M |
|---|
| 2025-06-30 | $360.24M |
|---|
| 2025-05-06 | $354.11M |
|---|
| 2025-03-31 | $388.07M |
|---|
| 2025-03-13 | $416.4M |
|---|
| 2024-12-31 | $710.88M |
|---|
| 2024-11-05 | $831.22M |
|---|
| 2024-09-30 | $771.75M |
|---|
| 2024-08-05 | $718.97M |
|---|
| 2024-06-30 | $644.37M |
|---|
| 2024-05-02 | $372.72M |
|---|
| 2024-03-31 | $311.57M |
|---|
| 2024-03-21 | $325.71M |
|---|
| 2023-12-31 | $321.82M |
|---|
| 2023-11-02 | $355.05M |
|---|
| 2023-09-30 | $296.56M |
|---|
| 2023-08-03 | $391.2M |
|---|
| 2023-06-30 | $415.06M |
|---|
| 2023-05-08 | $431.16M |
|---|
| 2023-03-31 | $450.6M |
|---|
| 2023-03-16 | $486.4M |
|---|
| 2022-12-31 | $643.63M |
|---|
| 2022-11-02 | $896.91M |
|---|
| 2022-09-30 | $943.99M |
|---|
| 2022-08-04 | $996.72M |
|---|
| 2022-06-30 | $671.44M |
|---|
| 2022-05-05 | $899.31M |
|---|
| 2022-03-31 | $1.03B |
|---|
| 2022-03-17 | $1.35B |
|---|
| 2021-12-31 | $1.86B |
|---|
| 2021-11-04 | $2.46B |
|---|
| 2021-09-30 | $2.52B |
|---|
| 2021-08-15 | $2.43B |
|---|
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|
| Dianthus Therapeutics, Inc. /DE/ (DNTH) | United States | $5.082B | -27.79 |
|---|
| PTC THERAPEUTICS, INC. (PTCT) | United States | $5.199B | -177.07 |
|---|
| Veradermics, Inc (MANE) | United States | $4.839B | |
|---|
| Gossamer Bio, Inc. (GOSS) | United States | $5.355B | -0.65 |
|---|
| Cogent Biosciences, Inc. (COGT) | United States | $5.450B | -17.61 |
|---|
| Oruka Therapeutics, Inc. (ORKA) | United States | $5.663B | -43.76 |
|---|
| Edgewise Therapeutics, Inc. (EWTX) | United States | $4.470B | -22.23 |
|---|
| Travere Therapeutics, Inc. (TVTX) | United States | $5.712B | -123.10 |
|---|
| Mirum Pharmaceuticals, Inc. (MIRM) | United States | $5.798B | -8.81 |
|---|
| Viking Therapeutics, Inc. (VKTX) | United States | $4.287B | -8.51 |
|---|